ARRIVE BIO

arrive-bio-logo

Arrive Bio develops therapies that improve healthspan.

#SimilarOrganizations #People #Website #More

ARRIVE BIO

Social Links:

Industry:
Biotechnology Pharmaceutical Therapeutics

Founded:
2019-01-01

Address:
Singapore, Central Region, Singapore

Country:
Singapore

Website Url:
http://www.arrivebio.com

Total Employee:
11+

Status:
Active

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Tag Manager Google Analytics SSL By Default Global Site Tag HSTS Google Analytics 4


Similar Organizations

artugen-therapeutics-logo

Artugen Therapeutics

Artugen Therapeutics develops biotherapeutic products.

avid-radiopharmaceuticals-logo

Avid Radiopharmaceuticals

Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

clario-logo

Clario

Clario delivers the endpoint technology solutions for clinical trials.

longevity-biotech-logo

Longevity Biotech

Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.

saphtx-logo

Saphtx

Saphtx develops protein-based therapeutic strategies for a wide range of diseases.

tivorsan-pharmaceuticals-logo

Tivorsan Pharmaceuticals

Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.

weiben-pharmaceutical-logo

Weiben Pharmaceutical

Weiben Pharmaceutical develops innovative drugs with targets such as c-myc and CaMKIIγ.

Current Employees Featured

anuj-gaggar_image

Anuj Gaggar
Anuj Gaggar Co-Founder and CEO @ Arrive Bio
Co-Founder and CEO
2021-04-01

Founder


anuj-gaggar_image

Anuj Gaggar

Official Site Inspections

http://www.arrivebio.com

  • Host name: 151.101.1.195
  • IP address: 151.101.1.195
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Arrive Bio"

Arrive

Arrive is a biotechnology company developing therapies for age-related diseases by applying cutting edge deep learning to complex biologic systems.See details»

Arrive Bio - Crunchbase Company Profile & Funding

Arrive Bio develops therapies that improve healthspan. Singapore, Central Region, Singapore; 11-50; Private; arrivebio.com ; 465,016; HighlightsSee details»

ARRIVE BIO, LLC - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for ARRIVE BIO, LLC of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»

Arrive Bio - LinkedIn

Arrive Bio Biotechnology Research A biotech company developing therapies that improve healthspan for all people.See details»

Arrive - Products, Competitors, Financials, Employees, …

Arrivebio.com. Overview & Products; People; Founded Year 2019. About Arrive. Arrive is a biotechnology company focused on revolutionizing target discovery for age-related diseases. …See details»

Arrive Bio - Drug pipelines, Patents, Clinical trials - Synapse

Explore Arrive Bio with its drug pipeline, therapeutic area, technology platform, 3 news.See details»

Arrive Bio Overview | SignalHire Company Profile

Be always one step ahead in your competition! Cut your recruitment and lead generation time by 85% with SignalHireSee details»

Arrive Bio - LinkedIn

Arrive Bio | 903 followers on LinkedIn. A biotech company developing therapies that improve healthspan for all people. | In Arrive, we are here to develop therapies to improve healthspan …See details»

Arrive Bio - VentureRadar

Website: https://arrivebio.com/ Provides innovative pharmaceutical discovery for age-related diseases using in vivo screening, machine learning, and bioinformatics to ...See details»

Arrive Bio - Longevity List

About: Arrive is a biotechnology company developing therapies for age-related diseases by applying cutting edge deep learning to complex biologic systems.See details»

Connect with us - arrivebio.com

Partnering. Arrive evaluates in-licensing opportunities from discovery through clinical stage assets. Please contact us with non-confidential partnership proposals or inquiries about …See details»

Arrive Bio LLC Overview - Salary.com

Discover essential details about Arrive Bio LLC, including address, contact, and journey of our company's evolution.See details»

Arrive Bio Staff Directory & Email Format - ContactOut

Explore Arrive Bio staff directory for direct access to contact details on 24 employees including email format, email address and phone numbers.See details»

ArriveBio Solutions

ArriveBio is a biotechnology company applying in-vivo target screening with machine learning to age-related diseases. Founded in New York. 2023. Offices in. New York & Singapore. …See details»

Arrive Bio profiles - FinalScout

In Arrive, we are here to develop therapies to improve healthspan for all people. Founded in Silicon Valley with a proprietary technology platform that accelerates pharmaceutical drug …See details»

Focus on key drivers of ageing. - arrivebio.com

Focus on key drivers of ageing. There are currently over 720 million persons over the age of 65 globally which is expected to double by 2050 to >1.5 billion.¹ Diseases of ageing, including …See details»

Arrive bio - Email Address & Phone Number - Lusha

Www.arrivebio.com. In Arrive, we are here to develop therapies to improve healthspan for all people. Founded in Silicon Valley with a proprietary technology platform that accelerates …See details»

Arrivo BioVentures LLC - Crunchbase Company Profile & Funding

Organization. Arrivo BioVentures LLC . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Arrivo BioVentures is a …See details»

ARRIVO BIOVENTURES

We are experienced. We are curious. We are problem solvers. At Arrivo, we strive to set a new standard in drug development that starts with the selection of drug candidates and runs …See details»

Arrivo BioVentures - Overview, News & Similar companies

Jan 3, 2024 Arrivo Bio Initiates Large Phase 2b Clinical Trial in Major Depressive Disorder with Novel SIRT6 Activator MORRISVILLE, N.C.--(BUSINESS WIRE)--Arrivo Bio announced today …See details»

linkstock.net © 2022. All rights reserved